16:09 EST Cadrenal Therapeutics (CVKD) files to sell 590K shares of common stock for holders
Maximize Your Portfolio with Data Driven Insights:
- Leverage the power of TipRanks' Smart Score, a data-driven tool to help you uncover top performing stocks and make informed investment decisions.
- Monitor your stock picks and compare them to top Wall Street Analysts' recommendations with Your Smart Portfolio
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CVKD:
- Cadrenal Therapeutics target adjusted to $32 from $3 at H.C. Wainwright
- Cadrenal Therapeutics Advances Tecarfarin Development
- Cadrenal Therapeutics Raises $5.1 Million for Tecarfarin
- Cadrenal Therapeutics raises $5.1M via at-the-market facility
- Cadrenal Therapeutics Unveils Phase 3 Trials and Market Strategy